Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Response to "Late relapse rates in patients with early-stage hormone receptor positive and HER2+ breast cancer treated with adjuvant chemotherapy and neoadjuvant chemotherapy".
Journal: Journal of surgical oncology
Published: February 07, 2020
Is there an association between body mass index and 21-gene recurrence score?
Journal: Surgical oncology
Published: August 12, 2019
Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience.
Journal: Journal of surgical oncology
Published: August 04, 2019
Impact of 21-Gene Expression Assay on Clinical Outcomes in Node-Negative ≤ T1b Breast Cancer.
Journal: Annals of surgical oncology
Published: July 29, 2019
Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?
Journal: Breast cancer research and treatment
Published: May 03, 2019
Showing 1-5 of 5
Last Updated: 09/26/2026